Drug Shortage Report for CEFAZOLIN FOR INJECTION USP
| Report ID | 64225 |
| Drug Identification Number | 02308932 |
| Brand name | CEFAZOLIN FOR INJECTION USP |
| Common or Proper name | CEFAZOLIN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFAZOLIN |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10PSOIJ |
| ATC code | J01DB |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2018-07-02 |
| Estimated end date | 2020-05-01 |
| Actual end date | 2020-05-04 |
| Shortage status | Resolved |
| Updated date | 2020-05-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2020-05-05 | English | Compare |